Koyfin Home > Directory > Health Care > Albireo Pharma Inc > Cash from Investing Activities

Albireo Pharma Inc Cash from Investing Activities Chart (ALBO)

Albireo Pharma Inc annual/quarterly Cash from Investing Activities from 2016 to 2020.
  • Albireo Pharma Inc Cash from Investing Activities for the quarter ending June 06, 2020 was $0m a -424.36% increase of 0m year over year
  • Albireo Pharma Inc Cash from Investing Activities for the last 12 months ending June 06, 2020 was $0m a -150.24% increase of 0m year over year
  • Albireo Pharma Inc Annual Cash from Investing Activities for 2019 was $-1m a 91.30% decrease of 0m from 2018
  • Albireo Pharma Inc Annual Cash from Investing Activities for 2018 was $0m a 9,270.21% decrease of -4m from 2017
  • Albireo Pharma Inc Annual Cash from Investing Activities for 2017 was $4m a -491.18% decrease of -21m from 2016
Other Cash Flow Metrics:
  • Albireo Pharma Inc Cash Flow from Operations for the quarter ending December 12, 2018 was $-10m a 110.98% decrease of -11m year over year
  • Albireo Pharma Inc Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $-10m a 91.45% decrease of -10m year over year
  • Albireo Pharma Inc Total Revenue for the quarter ending September 09, 2018 was $0m a 100.42% increase of 0m year over year
View Chart On Koyfin

Quarterly ALBO Cash from Investing Activities Data

06/2020$0m
12/2019$0m
09/2019$0m
06/2019$0m
12/2018$0m
09/2018$0m
06/2018$0m
03/2018$0m
12/2017$4m
09/2017$0m

Annual ALBO Cash from Investing Activities Data

2019$-1m
2018$0m
2017$4m
2016$25m
2014$0m